IL-1β regulation of Zika-mediated adverse perinatal outcomes
IL-1β 调节 Zika 介导的不良围产期结局
基本信息
- 批准号:10438667
- 负责人:
- 金额:$ 13.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-21 至 2022-10-03
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAffectAfrican AmericanAntiviral AgentsAsianBirthBrainCommunicationCongenital AbnormalityDataDevelopmentDiseaseDoseEmbryo TransferFamilyFemaleFetal DevelopmentFetusFlaviviridaeGeneticGestational AgeImmunocompetentImmunomodulatorsInfectionInflammasomeInflammationInflammatoryInterleukin-1 ReceptorsInterleukin-1 betaInterventionKineretKineticsLeadMediatingMicrocephalyModelingMouse StrainsNatureNeonatalNervous System TraumaNeurologic DeficitOutcomePathogenesisPerinatalPerinatal Brain InjuryPharmaceutical PreparationsPharmacologyPlacentaPregnancyProblem behaviorProductionPublishingRNA VirusesReceptor SignalingRecombinantsRegulationResearch ProposalsRoleSex DifferencesSignal TransductionTestingTherapeutic InterventionThinnessTranslational ResearchVaccinesViral Load resultViral PathogenesisWild Type MouseZIKAZIKV infectionZika Virusadverse outcomebrain abnormalitiescongenital infectionearly pregnancyexperimental studyfetalfetal brain injuryfetal infectionimmunopathologyimprovedin uterointrauterine infectionintrauterine inflammationlong-term sequelaemouse modelneurobehavioralneurotoxicitynoveloffspringperinatal medicineperinatal outcomesplacental infectionpregnantprenatal exposurereceptorreceptor bindingresponsesextherapeutically effectivetool
项目摘要
SUMMARY
Zika virus (ZIKV) infection of pregnant females results in congenital infection of offspring and long-term
developmental birth defects. Using an immunocompetent mouse model that we developed (published in
Nature Communications), we have shown that intrauterine infection with either African, American, or Asian
strains of ZIKV during early, but not late, pregnancy causes infection of the placenta and fetuses, placental
inflammation, neonatal cortical thinning, and short-term neurologic deficits in offspring. More recently, we have
demonstrated that placental IL-1β concentrations are elevated in ZIKV-infected dams, and we can reverse the
ZIKV-associated short-term neurobehavioral sequelae in offspring by blocking IL-1 receptor signaling during
the infection. We hypothesize that placental inflammation following intrauterine ZIKV infection causes perinatal
neurological injury, which can then be reversed by targeting maternal IL-1β signaling. While most ZIKV
interventions focus on antivirals and vaccines to limit perinatal ZIKV infection, to date no studies have
considered the role of maternal and placental inflammation as a mechanism mediating long-term adverse
perinatal outcomes following ZIKV infection. Specific Aim 1 will assess the mechanisms mediating elevated IL-
1β signaling in the placenta at different gestational ages following ZIKV infection, the long-term downstream
effects of the placental immunopathology and placental IL-1β signaling, and whether these effects are sex-
specific. In particular, Aim 1 will determine how placental inflammasome activation, IL-1β release, or
engagement of the IL-1 receptor lead to adverse perinatal outcomes. Specific Aim 2 will examine the
importance of maternal as opposed to fetal IL-1β signaling in the pathogenesis of perinatal brain injury
following ZIKV infection. Using embryo transfer of IL-1β signaling deficient and wild type mouse strains, Aim 2
will assess whether IL-1β activity of maternal origin is critical for sex-specific fetal brain injury. Our novel
translational research proposal, utilizing a ZIKV model that we developed, will have a significant impact on
perinatal medicine as it will lead to a better understanding of the role of placental inflammation in the
pathogenesis of fetal congenital diseases caused by infection or other inflammatory states during pregnancy.
概括
怀孕女性感染寨卡病毒(ZIKV)会导致后代先天性感染并长期感染
使用我们开发的免疫活性小鼠模型(发表于
《自然通讯》),我们已经证明,非洲、美洲或亚洲人的宫内感染
寨卡病毒株在妊娠早期(而非晚期)会导致胎盘和胎儿感染,胎盘
最近,我们发现了后代的炎症、新生儿皮质变薄和短期神经功能缺陷。
感染 ZIKV 的母鼠的胎盘 IL-1β 浓度升高,我们可以逆转
通过阻断 IL-1 受体信号传导,在后代中产生与 ZIKV 相关的短期神经行为后遗症
我们追查宫内 ZIKV 感染后的胎盘炎症会导致围产期。
神经损伤,然后可以通过针对母体 IL-1β 信号传导来逆转,而大多数 ZIKV 则可以逆转这种损伤。
干预措施的重点是抗病毒药物和疫苗,以限制围产期 ZIKV 感染,迄今为止尚无研究表明
认为母体和胎盘炎症作为介导长期不良反应的机制的作用
ZIKV 感染后的围产期结局具体目标 1 将评估介导 IL-升高的机制。
ZIKV 感染后不同胎龄胎盘中的 1β 信号传导是长期下游
胎盘免疫病理学和胎盘 IL-1β 信号传导的影响,以及这些影响是否与性别相关
特别是,目标 1 将确定胎盘炎症小体如何激活、IL-1β 释放或如何发生。
IL-1 受体的参与会导致不良的围产期结局。
母体对胎儿 IL-1β 信号的重要性在围产期脑损伤的发病机制中相反
ZIKV 感染后使用 IL-1β 信号传导缺陷和野生型小鼠品系的胚胎移植,目标 2
将评估母体来源的 IL-1β 活性是否对性别特异性胎儿脑损伤至关重要。
利用我们开发的 ZIKV 模型的转化研究提案将对
围产期医学,因为它将有助于更好地了解胎盘炎症在胎儿发育过程中的作用
妊娠期感染或其他炎症状态引起的胎儿先天性疾病的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IRINA BURD其他文献
IRINA BURD的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IRINA BURD', 18)}}的其他基金
Placental Serum Amyloid A as a Therapeutic Target to Prevent Preterm Birth and Prematurity Related Morbidity
胎盘血清淀粉样蛋白 A 作为预防早产和早产相关发病的治疗靶点
- 批准号:
10742411 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
IL-1B regulation of Zika-Mediated adverse perinatal outcomes
IL-1B 对寨卡介导的不良围产期结局的调节
- 批准号:
10782381 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
基于纳米医学的方法,用于表征表观基因组以预防炎症引起的早产。
- 批准号:
10586624 - 财政年份:2022
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
预防炎症引起的早产的纳米医学方法
- 批准号:
10392489 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
7/24 Healthy Brain and Child Development National Consortium
7/24 健康大脑和儿童发展国家联盟
- 批准号:
10380210 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
预防炎症引起的早产的纳米医学方法
- 批准号:
10591822 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
预防炎症引起的早产的纳米医学方法
- 批准号:
10406669 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
预防炎症引起的早产的纳米医学方法
- 批准号:
10211305 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
Nanomedicine approaches for prevention of inflammation-induced preterm birth
预防炎症引起的早产的纳米医学方法
- 批准号:
10592363 - 财政年份:2021
- 资助金额:
$ 13.81万 - 项目类别:
Placental determinants of neonatal immune function in maternal HIV infection
孕产妇艾滋病毒感染中新生儿免疫功能的胎盘决定因素
- 批准号:
9900843 - 财政年份:2019
- 资助金额:
$ 13.81万 - 项目类别:
相似国自然基金
儿童药品不良反应主动监测中时序处理策略的方法学研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于真实世界医疗大数据的中西药联用严重不良反应监测与评价关键方法研究
- 批准号:82274368
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于隐狄利克雷分配模型的心血管系统药物不良反应主动监测研究
- 批准号:82273739
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于真实世界数据的创新药品上市后严重罕见不良反应评价关键方法研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
OR10G7错义突变激活NLRP3炎症小体致伊马替尼严重皮肤不良反应的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 13.81万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Nursing homes' visitation bans during the COVID-19 pandemic: Effectiveness and consequences.
COVID-19 大流行期间疗养院的探视禁令:有效性和后果。
- 批准号:
10635829 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Targeting Alcohol-Opioid Co-Use Among Young Adults Using a Novel MHealth Intervention
使用新型 MHealth 干预措施针对年轻人中酒精与阿片类药物的同时使用
- 批准号:
10456380 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别:
Development of a digital therapeutic targeting anxiety sensitivity to reduce PTSD-SUD in women presenting for emergency care after sexual assault.
开发一种针对焦虑敏感性的数字疗法,以减少性侵犯后寻求紧急护理的女性的 PTSD-SUD。
- 批准号:
10449766 - 财政年份:2023
- 资助金额:
$ 13.81万 - 项目类别: